Harlaar, Niels http://orcid.org/0000-0003-2790-8708
Dekker, Sven O.
Zhang, Juan
Snabel, Rebecca R. http://orcid.org/0000-0001-8053-1191
Veldkamp, Marieke W.
Verkerk, Arie O. http://orcid.org/0000-0003-2140-834X
Fabres, Carla Cofiño
Schwach, Verena
Lerink, Lente J. S.
Rivaud, Mathilde R.
Mulder, Aat A.
Corver, Willem E.
Goumans, Marie José T. H. http://orcid.org/0000-0001-9344-6746
Dobrev, Dobromir
Klautz, Robert J. M.
Schalij, Martin J.
Veenstra, Gert Jan C. http://orcid.org/0000-0002-7787-4940
Passier, Robert http://orcid.org/0000-0003-4312-9296
van Brakel, Thomas J.
Pijnappels, Daniël A.
de Vries, Antoine A. F. http://orcid.org/0000-0002-4787-7155
Article History
Received: 20 October 2020
Accepted: 29 October 2021
First Online: 6 January 2022
Competing interests
: M.J.S., D.A.P. and A.A.F.d.V. are inventors of a patent application (US16/480,280, ‘Conditionally immortalized cells and methods for their preparation’) related to this work. R.P. is a cofounder of Pluriomics (Ncardia) and River Biomedics. D.D. is a member of the scientific advisory boards of OMEICOS Therapeutics and Acesion Pharma. All other authors declare no competing interests.